The addition of collagenase to BromAc® for the management of inoperable pseudomyxoma peritonei – in vitro results
Pseudomyxoma peritonei (PMP) is a rare peritoneal malignancy. BromAc® is a novel therapeutic agent which has been developed to dissolve and facilitate the drainage of mucin as a palliative treatment for PMP; however, its effect is significantly reduced in patients with hard mucin. This study aimed t...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
De Gruyter
2025-10-01
|
| Serier: | Pleura and Peritoneum |
| Fag: | |
| Online adgang: | https://doi.org/10.1515/pp-2025-0026 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|